Trials Sponsors Conditions Drugs Pricing

Conditions

Renal Stone Fragments ≤ 2mm Unilateral Ureteral Stone

Keywords

Renal StoneUreteroscopyUreteral Stentpost-uncomplicated ureteroscopyUURS

Outcome Measures

Primary Outcomes (1)

Safety
Composite of new-onset serious adverse event(s) including death, infection, the occurrence of surgery, re-hospitalization and or repeat hospitalization related to the device, or device related injury of the ureter.
90 days

Secondary Outcomes (2)

Technical Success
90 days
Pain
90 days

Study Arms (1)

Interventional

EXPERIMENTAL

Placement of ureteral stent following post-ureteroscopy

Device: Post-Ureteroscopy ADVA-Tec Uriprene™ Degradable Temporary Ureteral Stent

Interventions

Post-Ureteroscopy ADVA-Tec Uriprene™ Degradable Temporary Ureteral StentDevice

Renal stent placed after uncomplicated uteroscopy

Also known as: Renal ureteral stent

Interventional

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age19 Years - 79 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

Patients who are \> 18, \< 80 years of age; inclusive of males and females.
Patients with unilateral ureteral or renal stone fragments \< 2mm, post-uncomplicated ureteroscopy (UURS).

Sponsors & Collaborators

Adva-Tec
Industrylead
University of British Columbia
Othercollaborator

Study Sites (1)

University of British Columbia

Vancouver, British Columbia, Canada

MeSH Terms

Conditions

Nephrolithiasis

Condition Hierarchy (Ancestors)

Kidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrolithiasisMale Urogenital Diseases

Study Officials

Ben Chew, MD
University of British Columbia
PRINCIPAL INVESTIGATOR

Enrollment

8 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: phase 1
Allocation: NA
Masking: NONE
Purpose: TREATMENT
Intervention Model: SINGLE GROUP
Sponsor Type: INDUSTRY
Responsible Party: SPONSOR

Study Record Dates

First Submitted

January 8, 2014

First Posted

January 10, 2014

Study Start

March 2014

Date type not reported

This date has not been verified as actual or estimated.

Feasibility Study of the Uriprene Stent Following Uncomplicated Ureteroscopy

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (2)

Study Arms (1)

Interventional

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (2)

Study Arms (1)

Interventional

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations